WallStreetZenWallStreetZen

NASDAQ: ETON
Eton Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ETON past revenue growth

How has ETON's revenue growth performed historically?
Company
42.6%
Industry
10.14%
Market
17.55%
ETON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ETON's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ETON's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ETON earnings and revenue history

Current Revenue
$32.6M
Current Earnings
-$936.0k
Current Profit Margin
-2.9%

ETON Return on Equity

Current Company
-6.2%
Current Industry
15.4%
Current Market
188%
ETON's Return on Equity (-6.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ETON announces earnings.

ETON Return on Assets

Current Company
-3.2%
Current Industry
3.4%
ETON is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ETON Return on Capital Employed

Current Company
-7.69%
Current Industry
5.1%
ETON has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ETON vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ETON$32.64M-$291.00k-$936.00k+141.54%N/A
OPTN$70.99M-$15.55M-$35.48M+58.64%N/A
ASRT$152.07M-$222.45M-$331.94M-13.38%N/A
EBS$1.05B-$518.20M-$760.50M+6.05%N/A
TKNO$36.68M-$30.45M-$36.78M+16.24%N/A
View Top Pharmaceutical Stocks

ETON earnings dates

Next earnings date
Jun 11, 2024

Eton Pharmaceuticals Earnings & Revenue FAQ

What were ETON's earnings last quarter?

On Invalid Date, Eton Pharmaceuticals (NASDAQ: ETON) reported Q4 2023 earnings per share (EPS) of -$0.09, up 325% year over year. Total Eton Pharmaceuticals earnings for the quarter were -$2.26 million. In the same quarter last year, Eton Pharmaceuticals's earnings per share (EPS) was $0.04.

If you're new to stock investing, here's how to buy Eton Pharmaceuticals stock.

What was ETON's earnings growth in the past year?

As of Q2 2024, Eton Pharmaceuticals's earnings has grown year over year. Eton Pharmaceuticals's earnings in the past year totalled -$936.00 thousand.

What is ETON's earnings date?

Eton Pharmaceuticals's earnings date is Invalid Date. Add ETON to your watchlist to be reminded of ETON's next earnings announcement.

What was ETON's revenue last quarter?

On Invalid Date, Eton Pharmaceuticals (NASDAQ: ETON) reported Q4 2023 revenue of $8.31 million up 9.13% year over year. In the same quarter last year, Eton Pharmaceuticals's revenue was $9.15 million.

What was ETON's revenue growth in the past year?

As of Q2 2024, Eton Pharmaceuticals's revenue has grown 42.6% year over year. This is 32.46 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.14%. Eton Pharmaceuticals's revenue in the past year totalled $32.64 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.